Paladin’s strategy is to leverage its strong sales and marketing capabilities with the acquisition and licensing of complementary products. Future growth will be fueled by the launch of innovative products – principally sourced from small to medium sized pharmaceutical and biotechnology companies with promising technology without sales and marketing capabilities in Canada.
Based on our proven track record for marketing and selling innovative pharmaceuticals in Canada, Paladin has become the partner of choice for these types of companies.
If you are interested in exploring potential licensing opportunities with Paladin, please contact:
Vice President, Business Development
Associate Director, Business Development